BIOCUBE INCORPORATED (OTCMKTS:BICB)’s Stock Is Buy After Less Market Selling

January 13, 2018 - By Stephen Andrade

The stock of BIOCUBE INCORPORATED (OTCMKTS:BICB) registered a decrease of 27.78% in short interest. BICB’s total short interest was 7,800 shares in January as published by FINRA. Its down 27.78% from 10,800 shares, reported previously. With 40,600 shares average volume, it will take short sellers 0 days to cover their BICB’s short positions.

It closed at $0.0191 lastly. It is down 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company has market cap of $1.15 million. The firm was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. It currently has negative earnings.

More recent BioCube, Inc. (OTCMKTS:BICB) news were published by: Bna.com which released: “Four Allegedly Used Marijuana Company to Scam Investors” on April 17, 2017. Also Philly.com published the news titled: “Center City lawyer charged in alleged stock scheme involving pot detector” on April 16, 2017. Businesswire.com‘s news article titled: “Spring Creek Capital Corp. Announces the Sale of its Interest in BioCube, Inc.” with publication date: September 13, 2010 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.